Published : Oct-2017
No. of Pages : 246
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Intraocular Lens (IOL) Overview 14
3 Products under Development 15
3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development 15
3.2 Intraocular Lens (IOL) - Pipeline Products by Segment 16
3.3 Intraocular Lens (IOL) - Pipeline Products by Territory 17
3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path 18
3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date 19
3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials 20
4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies 21
4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development 21
4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development 23
5 Intraocular Lens (IOL) Companies and Product Overview 28
5.1 Abbott Medical Optics Inc Company Overview 28
5.1.1 Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.2 Adoptics AG (Inactive) Company Overview 30
5.2.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 AkkoLens International BV Company Overview 31
5.3.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 31
5.4 Alcon Laboratories Inc Company Overview 32
5.4.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.5 Anew Optics, Inc. Company Overview 41
5.5.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.6 Bausch & Lomb Inc Company Overview 42
5.6.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Clarvista Medical, Inc. Company Overview 43
5.7.1 Clarvista Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 Elenza, Inc. Company Overview 47
5.8.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.9 Emmetrope Incorporated Company Overview 48
5.9.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Eye4Vision Ophthalmics International Company Overview 51
5.10.1 Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 51
5.11 EyeKon Medical Inc Company Overview 52
5.11.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 Hoya Surgical Optics Inc Company Overview 108
5.12.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 108
5.13 IFS Construction Services Ltd Company Overview 110
5.13.1 IFS Construction Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 110
5.14 InfiniteVision Optics, SAS Company Overview 111
5.14.1 InfiniteVision Optics, SAS Pipeline Products & Ongoing Clinical Trials Overview 111
5.15 Innovia LLC Company Overview 114
5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 114
5.16 LayerBio Inc Company Overview 115
5.16.1 LayerBio Inc Pipeline Products & Ongoing Clinical Trials Overview 115
5.17 LensGen, Inc. Company Overview 116
5.17.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.18 London Eye Hospital Pharma Company Overview 117
5.18.1 London Eye Hospital Pharma Pipeline Products & Ongoing Clinical Trials Overview 117
5.19 Meir Medical Center Company Overview 118
5.19.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 118
5.20 Morcher Gmbh Company Overview 119
5.20.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 119
5.21 NuLens Ltd. (Inactive) Company Overview 141
5.21.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141
5.22 Ocumetics Technology Corp Company Overview 142
5.22.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 142
5.23 PowerVision, Inc. Company Overview 143
5.23.1 PowerVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143
5.24 Presbeasy Company Overview 146
5.24.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 146
5.25 Rayner Intraocular Lenses Ltd Company Overview 147
5.25.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview 147
5.26 RxSight Inc Company Overview 162
5.26.1 RxSight Inc Pipeline Products & Ongoing Clinical Trials Overview 162
5.27 Santen Pharmaceutical Co Ltd Company Overview 163
5.27.1 Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 163
5.28 Sharklet Technologies, Inc. Company Overview 164
5.28.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164
5.29 STAAR Surgical Company Company Overview 165
5.29.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 165
5.30 Strathspey Crown LLC Company Overview 170
5.30.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview 170
5.31 University of Rochester Company Overview 171
5.31.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 171
5.32 University of Tampere Company Overview 172
5.32.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 172
5.33 Valeant Pharmaceuticals International Inc Company Overview 173
5.33.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 173
5.34 Visidome Ltd Company Overview 174
5.34.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview 174
5.35 Visioneering Technologies Inc Company Overview 175
5.35.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 175
5.36 Washington University in St Louis Company Overview 176
5.36.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 176
5.37 Xend Company Overview 177
5.37.1 Xend Pipeline Products & Ongoing Clinical Trials Overview 177
5.38 Z Lens LLC Company Overview 178
5.38.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 178
6 Intraocular Lens (IOL)- Recent Developments 179
6.1 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 179
6.2 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, LUCIDIS 179
6.3 Sep 15, 2017: Swiss Advanced Vision Announces Launch of New Intraocular Lens, EDEN 180
6.4 Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts 180
6.5 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 180
6.6 Sep 07, 2017: Industry Leader Dr. Doug Benoit Joins VTI as Executive Director of Professional Affairs 181
6.7 Aug 15, 2017: World's fastest growing IOL Company - Opens Second Manufacturing Facility in Thailand 182
6.8 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 182
6.9 Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results 185
6.10 Aug 01, 2017: Visioneering Technologies Announces Lynn Cali-Cianci As Executive Territory Manager, New York City/Long Island 186
6.11 Jul 27, 2017: Hoya Reports First Quarter Financial Results 187
6.12 Jul 25, 2017: Visioneering Technologies Appoints Lisa Humble as Senior Territory Manager For North and South Carolina 187
6.13 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 188
6.14 Jul 20, 2017: Dr. Jim Raulino Joins the VTI Team as Executive Territory Manager for Sacramento and Reno 190
6.15 Jul 13, 2017: Visioneering Technologies Appoints Michelle Kirst as Territory Manager for New Jersey 190
6.16 Jul 11, 2017: Visioneering Technologies Appoints Ron Makelke as Territory Manager for San Francisco 191
6.17 Jul 06, 2017: Visioneering Technologies Appoints Carol Baez as Executive Territory Manager for Orange County/San Diego 191
6.18 Jun 27, 2017: Visioneering Technologies Names Mark Rapoport as New CFO 192
6.19 Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International 192
6.20 Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications 193
6.21 Jun 19, 2017: John Paulson Joins Valeant Board Of Directors 193
6.22 Jun 14, 2017: The Eye Institute of Utah Now Offering FDA-Approved Acrysof IQ ReSTOR +2.5 Multifocal Toric IOL with ACTIVEFOCUS for Cataract Surgery 193
6.23 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 194
6.24 May 11, 2017: STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic 195
6.25 May 11, 2017: Hoya Reports Fourth Quarter and Full-Year Financial Results 195
6.26 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 196
6.27 May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance 197
6.28 May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range 197
6.29 May 08, 2017: ZEISS Appoints New Fellow 198
6.30 May 08, 2017: Systemic therapy outperforms intraocular implant for treating uveitis 199
6.31 May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership 200
6.32 May 03, 2017: Las Vegas Cataract Surgeon Says the TECNIS Symfony Intraocular Lens Offers Patients an Excellent New Lifestyle Option 201
6.33 May 03, 2017: Alcon launches newly approved Multifocal Toric IOL with ACTIVEFOCUS optical design, highlights other surgical innovations at the American Society of Cataract and Refractive Surgery 2017 annual meeting 202
6.34 May 03, 2017: STAAR Surgical Reports First Quarter 2017 Results 205
6.35 Apr 25, 2017: ZEISS Opens New Microscopy Customer Center 206
6.36 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 206
6.37 Apr 05, 2017: STAAR Surgical Names Deborah Andrews Interim CFO 209
6.38 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 209
6.39 Mar 27, 2017: Carl Zeiss Meditec wins patent infringement action on trifocal intraocular lens against VSY Biotechnology and Fritz Ruck Ophthalmologische Systeme 210
6.40 Mar 23, 2017: Alcon Receives US FDA Approval For New AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL With ACTIVEFOCUS Design For Uncompromised Distance Vision And Presbyopia Correction 210
6.41 Mar 22, 2017: ClarVista Medical Completes Important Milestone to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement 211
6.42 Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments 211
6.43 Mar 02, 2017: STAAR Surgical Reports Fourth Quarter 2016 Results 213
6.44 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance 214
6.45 Feb 23, 2017: Calhoun Vision Becomes RxSight 218
6.46 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 219
6.47 Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 220
6.48 Jan 31, 2017: Hoya Announces Third Quarter Financial Results 220
6.49 Jan 26, 2017: Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery 220
6.50 Jan 17, 2017: Visioneering Technologies Announces Jeff Babbe as New Executive Territory Manager for Chicago, IL 221
6.51 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors 222
6.52 Dec 23, 2016: Alcon receives US FDA approval for AcrySof IQ ReSTOR +3.0D Multifocal Toric intraocular lens for cataract patients 222
6.53 Dec 21, 2016: Visioneering Technologies Announces Brian Atkinson as Territory Manager for the Dallas/Ft. Worth Market 223
6.54 Dec 13, 2016: Visioneering Technologies Announces Ken Gold as New Executive Territory Manager for the Baltimore-Washington, DC Area 223
6.55 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology 224
6.56 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 224
6.57 Dec 07, 2016: VTI names executive director of manufacturing and engineering 225
6.58 Dec 07, 2016: Visioneering Technologies Announces Ms. Rosa Lee as New Executive Director of Manufacturing & Engineering 226
6.59 Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme 226
6.60 Nov 16, 2016: Center For Sight Offers Las Vegas Cataract Patients New Extended Depth of Focus Lens Implants for Reduced Dependence on Glasses 228
6.61 Nov 09, 2016: Redding Eye Surgeon Announces Arrival of FDA-Approved TECNIS Symfony Intraocular Lenses 229
6.62 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results 230
6.63 Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results 233
6.64 Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016 234
6.65 Oct 28, 2016: Hoya Reports Second Quarter Results 235
6.66 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 235
6.67 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 238
6.68 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago 239
6.69 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer 241
6.70 Oct 03, 2016: Santen: Personnel Changes of Corporate Officer 242
7 Appendix 243
7.1 Methodology 243
7.2 About GlobalData 246
7.3 Contact Us 246
7.4 Disclaimer 246
1.1 List of Tables
Table 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development 15
Table 2: Intraocular Lens (IOL) - Pipeline Products by Segment 16
Table 3: Intraocular Lens (IOL) - Pipeline Products by Territory 17
Table 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path 18
Table 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date 19
Table 6: Intraocular Lens (IOL) - Ongoing Clinical Trials 20
Table 7: Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development 21
Table 8: Intraocular Lens (IOL) - Pipeline Products by Stage of Development 23
Table 9: Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 10: Intraocular Lens - Astigmatism - Product Status 28
Table 11: Intraocular Lens - Astigmatism - Product Description 28
Table 12: Intraocular Lens - Presbyopia - Product Status 29
Table 13: Intraocular Lens - Presbyopia - Product Description 29
Table 14: Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
Table 15: Shape-Changing Accommodating Intraocular Lens - Product Status 30
Table 16: Shape-Changing Accommodating Intraocular Lens - Product Description 30
Table 17: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 31
Table 18: AkkoLens AIOL - Product Status 31
Table 19: AkkoLens AIOL - Product Description 31
Table 20: Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 21: Accommodative Intraocular Lens - Product Status 32
Table 22: Accommodative Intraocular Lens - Product Description 33
Table 23: AcrySof Cachet Angle-Supported Phakic Lens - Product Status 33
Table 24: AcrySof Cachet Angle-Supported Phakic Lens - Product Description 33
Table 25: AcrySof IQ PanOptix Toric IOL - Product Status 34
Table 26: AcrySof IQ PanOptix Toric IOL - Product Description 34
Table 27: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status 34
Table 28: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description 35
Table 29: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status 35
Table 30: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description 35
Table 31: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status 35
Table 32: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description 36
Table 33: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status 36
Table 34: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description 36
Table 35: AcrySof IQ Toric Diopter Range Expansion - Product Status 36
Table 36: AcrySof IQ Toric Diopter Range Expansion - Product Description 37
Table 37: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status 37
Table 38: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description 37
Table 39: Intrepid IOL - Product Status 38
Table 40: Intrepid IOL - Product Description 38
Table 41: Alcon Laboratories Inc - Ongoing Clinical Trials Overview 39
Table 42: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Patient-reported Satisfaction and Spectacle Independence with the ReSTOR 2.5 Combined with the ReSTOR 3.0 IOL in Cataract Surgery 40
Table 43: Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 44: Zephyr Lens - Product Status 41
Table 45: Zephyr Lens - Product Description 41
Table 46: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 47: Sarfarazi Elliptical Accommodating IOL - Product Status 42
Table 48: Sarfarazi Elliptical Accommodating IOL - Product Description 42
Table 49: Clarvista Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 50: HARMONI Modular IOL - Product Status 43
Table 51: HARMONI Modular IOL - Product Description 43
Table 52: Second Generation HARMONI System - Product Status 44
Table 53: Second Generation HARMONI System - Product Description 44
Table 54: Clarvista Medical, Inc. - Ongoing Clinical Trials Overview 45
Table 55: HARMONI Modular IOL - Feasibility of HARMONI Modular IOL in Restoration of Vision of Patients after Cataract Surgery 46
Table 56: Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 57: Sapphire Autofocal IOL - Product Status 47
Table 58: Sapphire Autofocal IOL - Product Description 47
Table 59: Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 48
Table 60: ActaLens - Product Status 48
Table 61: ActaLens - Product Description 48
Table 62: ActaLens-Duo - Product Status 49
Table 63: ActaLens-Duo - Product Description 49
Table 64: ActaLens-SC - Product Status 49
Table 65: ActaLens-SC - Product Description 50
Table 66: Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 51
Table 67: HYDROPHOBICx - Product Status 51
Table 68: HYDROPHOBICx - Product Description 51
Table 69: EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 70: ACUITY FA55A-4NY IOL - Product Status 54
Table 71: ACUITY FA55A-4NY IOL - Product Description 54
Table 72: Acuity FA55A-4UV IOL - Product Status 54
Table 73: Acuity FA55A-4UV IOL - Product Description 55
Table 74: Acuity FB25B - UV IOL - Product Status 55
Table 75: Acuity FB25B - UV IOL - Product Description 55
Table 76: Acuity FB25B-NY IOL - Product Status 56
Table 77: Acuity FB25B-NY IOL - Product Description 56
Table 78: Acuity FS25B-NY IOL - Product Status 56
Table 79: Acuity FS25B-NY IOL - Product Description 57
Table 80: Acuity FS25B-UV IOL - Product Status 57
Table 81: Acuity FS25B-UV IOL - Product Description 57
Table 82: Acuity FS60S - 4NY IOL - Product Status 58
Table 83: Acuity FS60S - 4NY IOL - Product Description 58
Table 84: Acuity FS60S - 4UV IOL - Product Status 58
Table 85: Acuity FS60S - 4UV IOL - Product Description 59
Table 86: Acuity TN60-2NY IOL - Product Status 59
Table 87: Acuity TN60-2NY IOL - Product Description 59
Table 88: Acuity TN60-OUV IOL - Product Status 60
Table 89: Acuity TN60-OUV IOL - Product Description 60
Table 90: Acurus AB60 - OUV IOL - Product Status 60
Table 91: Acurus AB60 - OUV IOL - Product Description 61
Table 92: Acurus AY60 - OUV IOL - Product Status 61
Table 93: Acurus AY60 - OUV IOL - Product Description 61
Table 94: AQ204 Natural Clear IOL - Product Status 62
Table 95: AQ204 Natural Clear IOL - Product Description 62
Table 96: Cirrus CB60-OUV IOL - Product Status 62
Table 97: Cirrus CB60-OUV IOL - Product Description 63
Table 98: Cirrus CN60-2NY IOL - Product Status 63
Table 99: Cirrus CN60-2NY IOL - Product Description 63
Table 100: Cirrus CN60-OUV IOL - Product Status 64
Table 101: Cirrus CN60-OUV IOL - Product Description 64
Table 102: Cirrus CS25B-1 IOL - Product Status 64
Table 103: Cirrus CS25B-1 IOL - Product Description 65
Table 104: Cirrus CS25B-NY IOL - Product Status 65
Table 105: Cirrus CS25B-NY IOL - Product Description 65
Table 106: Cirrus CS60S-4 IOL - Product Status 66
Table 107: Cirrus CS60S-4 IOL - Product Description 66
Table 108: Cirrus CS60S-4NY IOL - Product Status 66
Table 109: Cirrus CS60S-4NY IOL - Product Description 67
Table 110: Cirrus CY60-OUV IOL - Product Status 67
Table 111: Cirrus CY60-OUV IOL - Product Description 67
Table 112: DGR AS55A-4NY IOL - Product Status 68
Table 113: DGR AS55A-4NY IOL - Product Description 68
Table 114: DGR AS55A-4UV IOL - Product Status 68
Table 115: DGR AS55A-4UV IOL - Product Description 69
Table 116: DGR DB60B-OUV IOL - Product Status 69
Table 117: DGR DB60B-OUV IOL - Product Description 69
Table 118: DGR DN60B-2NY IOL - Product Status 70
Table 119: DGR DN60B-2NY IOL - Product Description 70
Table 120: DGR DN60B-OUV IOL - Product Status 70
Table 121: DGR DN60B-OUV IOL - Product Description 71
Table 122: DGR DY60B-OUV IOL - Product Status 71
Table 123: DGR DY60B-OUV IOL - Product Description 71
Table 124: DGR SB25B IOL - Product Status 72
Table 125: DGR SB25B IOL - Product Description 72
Table 126: DGR SB25B-NY IOL - Product Status 72
Table 127: DGR SB25B-NY IOL - Product Description 73
Table 128: DGR SC25B-ONY IOL - Product Status 73
Table 129: DGR SC25B-ONY IOL - Product Description 73
Table 130: DGR SC25B-OUV IOL - Product Status 74
Table 131: DGR SC25B-OUV IOL - Product Description 74
Table 132: DGR SP60S-4NY IOL - Product Status 74
Table 133: DGR SP60S-4NY IOL - Product Description 75
Table 134: DGR SP60S-4UV IOL - Product Status 75
Table 135: DGR SP60S-4UV IOL - Product Description 75
Table 136: DGR ZF25B-ONY IOL - Product Status 76
Table 137: DGR ZF25B-ONY IOL - Product Description 76
Table 138: DGR ZF25B-OUV IOL - Product Status 76
Table 139: DGR ZF25B-OUV IOL - Product Description 77
Table 140: Eyekon EA55A IOL - Product Status 77
Table 141: Eyekon EA55A IOL - Product Description 77
Table 142: EyeKon EA55A NY IOL - Product Status 78
Table 143: EyeKon EA55A NY IOL - Product Description 78
Table 144: Eyekon EQ624 IOL - Product Status 78
Table 145: Eyekon EQ624 IOL - Product Description 79
Table 146: Eyekon EQ624 NY IOL - Product Status 79
Table 147: Eyekon EQ624 NY IOL - Product Description 79
Table 148: Eyekon HB60-OUV IOL - Product Status 80
Table 149: Eyekon HB60-OUV IOL - Product Description 80
Table 150: EyeKon HB60BF - NY IOL - Product Status 80
Table 151: EyeKon HB60BF - NY IOL - Product Description 81
Table 152: EyeKon HB60BF Natural Clear IOL - Product Status 81
Table 153: EyeKon HB60BF Natural Clear IOL - Product Description 81
Table 154: EyeKon HY60 OUV IOL - Product Status 82
Table 155: EyeKon HY60 OUV IOL - Product Description 82
Table 156: Eyekon MC25B - OUV IOL - Product Status 82
Table 157: Eyekon MC25B - OUV IOL - Product Description 83
Table 158: Eyekon MC60S - 4NY IOL - Product Status 83
Table 159: Eyekon MC60S - 4NY IOL - Product Description 83
Table 160: Eyekon MC60S - 4UV IOL - Product Status 84
Table 161: Eyekon MC60S - 4UV IOL - Product Description 84
Table 162: Eyekon MN60-OUV IOL - Product Status 84
Table 163: Eyekon MN60-OUV IOL - Product Description 85
Table 164: EyeKon NY204 IOL - Product Status 85
Table 165: EyeKon NY204 IOL - Product Description 85
Table 166: Eyekon NY25-Fold IOL - Product Status 86
1.2 List of Figures
Figure 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development 15
Figure 2: Intraocular Lens (IOL) - Pipeline Products by Segment 16
Figure 3: Intraocular Lens (IOL) - Pipeline Products by Territory 17
Figure 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path 18
Figure 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date 19
Figure 6: Intraocular Lens (IOL) - Ongoing Clinical Trials 20
